Results 51 to 60 of about 19,693 (207)
Moving through adulthood: The lived experience of Irish adults with PKU
BackgroundThis paper represents a portion of the findings from one of the first research studies eliciting the lived experience of adults with an early diagnosis of Phenylketonuria (PKU) living in Ireland.
Mary-Ellen O'Shea +3 more
doaj +1 more source
Development of a High‐Throughput Microarray Platform for Rapid, Low‐Cost Expanded Carrier Screening
ABSTRACT Objective To develop a customized expanded carrier screening (ECS) solution for 8271 variants of 265 genes. Based on a microarray platform, this solution demonstrates comparable accuracy to next‐generation sequencing (NGS) platform; however, it has a lower cost, a faster speed, and a simplified data—analysis process.
Jiazhen Chang +11 more
wiley +1 more source
Protein Substitutes in PKU; Their Historical Evolution
Protein substitutes developed for phenylketonuria (PKU) are a synthetic source of protein commonly based on L-amino acids. They are essential in the treatment of phenylketonuria (PKU) and other amino acid disorders, allowing the antagonistic amino acid ...
Anita MacDonald +4 more
core +1 more source
Figure 1 Patient selection flowchart. CCRT, concurrent chemoradiotherapy; NCCRT, nimotuzumab and concurrent chemoradiotherapy. Abstract Purpose Patients with locally advanced head and neck squamous cell carcinoma (LA‐HNSCC) harboring high‐risk pathological features after radical surgery face high recurrence rates.
Yuejia Zhou +8 more
wiley +1 more source
AI‐Enabled Automated Schistocyte Classification in Peripheral Blood for TMA Auxiliary Diagnosis
ABSTRACT Background Schistocytes are critical morphological markers for thrombotic microangiopathy (TMA) diagnosis. Manual identification is hampered by inconsistent standards and high interobserver variability, compromising accuracy. Although AI has advanced in hematology, AI‐enabled schistocyte classification remains under‐studied, creating a ...
Lei Shang +7 more
wiley +1 more source
Fenýlketónúría (PKU) : greinargerð með fræðslubæklingi um PKU
Eftirfarandi umfjöllun er 10 ECTS lokaverkefni til BA gráðu í þroskaþjálfafræði á Íþrótta-, tómstunda- og þroskaþjálfasviði Háskóla Íslands. Verkefnið er tvíþætt og inniheldur annars vegar bækling um meðfædda efnaskiptagallann fenýlketónúría (PKU) og ...
Eydís Eva Pálsdóttir 1989-
core +1 more source
Psychological well‐being of early and continuously treated phenylketonuria patients
Background Despite enormous advances in therapy, phenylketonuria (PKU) remains an incurable, inherited metabolic disease requiring life‐long treatment with potential to negatively impact quality of life and psychological well‐being. Therefore, the aim of
Alena Gerlinde Thiele +6 more
doaj +1 more source
ABSTRACT Background Adults with intellectual disability experience significant health issues that increase with age. Longitudinal analyses offer important evidence on how the trajectories of these conditions' develop and change. Methods Data were drawn from five waves of IDS‐TILDA, with a nationally representative sample of over 700 adults with ...
Martin McMahon +6 more
wiley +1 more source
ABSTRACT Background Obesity's global rise has outpaced the effectiveness of “one‐size‐fits‐all” prevention and treatment strategies. The promise of precision medicine lies in addressing the etiological and biological diversity of obesity and transforming it into actionable endotypes.
Nadia Abu Samra +13 more
wiley +1 more source
Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine Patients [PDF]
Phenylketonuria (PKU, OMIM 261600) is predominantly caused by mutations in the PAH gene. One hundred and three Argentine PKU patients were studied by Sanger sequencing; 101 were completely characterized (90.3% were compound heterozygotes).
Prieto, Laura +21 more
core +1 more source

